Scinovex
review Open AccessTop 1% cited

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Gut · 2019 · Vol. 68(Suppl 3) · pp. s1–s106
Christopher A LambNicholas A. KennedyTim RainePhilip HendyPhilip J SmithJimmy K. LimdiBu HayeeMiranda LomerGareth ParkesChristian P. SelingerKevin BarrettJustin DaviesCathy BennettStuart GittensMalcolm G. DunlopOmar FaizAileen FraserVikki GarrickPaul D JohnstonMiles ParkesJeremy SandersonHelen TerryIBD guidelines eDelphi consensus groupDaniel R. GayaTariq IqbalStuart A. TaylorMelissa SmithMatthew BrookesRichard HansenA. B. Hawthorne

Abstract

Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and within individuals over time. Optimal management relies on understanding and tailoring evidence-based interventions by clinicians in partnership with patients. This guideline for management of inflammatory bowel disease in adults over 16 years of age was developed by Stakeholders representing UK physicians (British Society of Gastroenterology), surgeons (Association of Coloproctology of Great Britain and Ireland), specialist nurses (Royal College of Nursing), paediatricians (British Society of Paediatric Gastroenterology, Hepatology and Nutrition), dietitians (British Dietetic Association), radiologists (British Society of Gastrointestinal and Abdominal Radiology), general practitioners (Primary Care Society for Gastroenterology) and patients (Crohn's and Colitis UK). A systematic review of 88 247 publications and a Delphi consensus process involving 81 multidisciplinary clinicians and patients was undertaken to develop 168 evidence- and expert opinion-based recommendations for pharmacological, non-pharmacological and surgical interventions, as well as optimal service delivery in the management of both ulcerative colitis and Crohn's disease. Comprehensive up-to-date guidance is provided regarding indications for, initiation and monitoring of immunosuppressive therapies, nutrition interventions, pre-, peri- and postoperative management, as well as structure and function of the multidisciplinary team and integration between primary and secondary care. Twenty research priorities to inform future clinical management are presented, alongside objective measurement of priority importance, determined by 2379 electronic survey responses from individuals living with ulcerative colitis and Crohn's disease, including patients, their families and friends.

Inflammatory Bowel DiseaseMicroscopic ColitisPregnancy and Medication ImpactMedicineInflammatory bowel diseaseUlcerative colitisPsychological interventionHepatologyInternal medicineDiseaseGuidelinePediatric gastroenterologyFamily medicine

MeSH terms

Conservative TreatmentConservative TreatmentSystematic Reviews as TopicAdultGastroenterologyUnited KingdomHumansSocieties, MedicalInflammatory Bowel DiseasesInflammatory Bowel DiseasesPractice Guidelines as TopicDisease ManagementConsensus

Funding

  • British Dietetic Association
  • National Institute for Health and Care Research
  • Crohn's and Colitis UK
  • Medical Research Council
Citations
2,254
FWCI
174.12
field-weighted impact
References
1,340
Percentile
100%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.